The 2024 ESMO Congress has highlighted significant advances in breast cancer research, aligning with Breast Cancer Canada’s mission to improve patient outcomes. Here are key findings from the congress that
The ESMO Congress 2024 is currently underway in Barcelona, serving as a global hub for the latest advancements in oncology. Researchers, healthcare professionals, and press representatives from around the world
At this week’s Connexions to Health Equity Summit, held by the Ontario Chamber of Commerce at the Sheraton Centre Toronto, Kimberly Carson, CEO of Breast Cancer Canada, delivered a compelling
Last week, Breast Cancer Canada had the privilege of participating in the Canada’s Drug Agency (CDA) Symposium 2024, held both in-person at the Ottawa Shaw Centre and virtually. The event,
The Breast Cancer Canada Translational Research Unit (BCC-TRU) at the London Health Sciences Centre is delighted to announce eight new scholarships and fellowships at Western University for the 2024-2025 academic
Breast Cancer Canada is excited to host an exclusive evening of networking and national research announcements at SABCS. We warmly invite Canadian oncologists, researchers, and industry leaders to connect with
We are thrilled to announce that Dr. Alison Allan, Director of Breast Cancer Canada’s Translational Research Unit at London Health Sciences Centre, has been appointed as the Associate Vice-President (Research)
Breast Cancer Canada is thrilled to celebrate a significant milestone in the organization’s journey toward advancing breast cancer research: Angela Marlatt, our Vice President, Mission and Advocacy, is being recognized
Quick Links
Sign Up, Know More.
